Surprise Me!
FDA approves Celltrion’s biosimilar drug Remsima for sales in U.S.
2016-04-06
2
Dailymotion
Advertise here
Advertise here
Related Videos
FDA approves Celltrion’s biosimilar drug Remsima for sales in U.S.
FDA approves Celltrion’s biosimilar drug Remsima for sales in U.S.
U.S. FDA approves emergency authorization of convalescent plasma to treat COVID-19 patients
U.S. FDA approves emergency authorization of convalescent plasma to treat COVID-19 patients
U.S. FDA approves continuation of AstraZeneca's Phase III COVID-19 vaccine trials in the U.S.
U.S. FDA approves genetically modified salmon for human consumption
U.S. FDA approves Moderna's COVID-19 vaccine
U.S. FDA approves first antigen test kit for COVID-19
U.S. FDA approves emergency authorization of convalescent plasma to treat COVID-19 patients
U.S. FDA approves Moderna vaccine for emergency use
